
Jayant Singh, Global Category Lead, Oral Health, and Haleon, said: “With oral diseases affecting nearly half the world’s population, this marks an exciting step forward in our mission to put health in more hands for millions across the world. This centre will play a key role in harnessing the full potential of science and innovation across our oral health portfolio.”Established as a corporate spin-off from GSK, Haleon plc (NYSE:HLN) has evolved into a global leader in consumer health. Its product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, Therapeutic Skin Health, and Others. While we acknowledge the potential of HLN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Consumer Goods Stocks Billionaires Are Quietly Buying and Goldman Sachs Penny Stocks: Top 12 Stock Picks. Disclosure: None. This article is originally published at Insider Monkey.
| Nov-04 | |
| Nov-04 | |
| Nov-02 | |
| Oct-30 | |
| Oct-29 | |
| Oct-29 | |
| Oct-20 | |
| Oct-19 | |
| Oct-12 | |
| Sep-28 | |
| Sep-25 | |
| Sep-23 | |
| Sep-17 | |
| Sep-16 | |
| Sep-09 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite